Healthy.Capital

We are inspired by a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. We invest in both solutions intended for use in the diagnosis or cure of disease and solutions designed to help healthcare organizations - be them hospitals, biopharmas, insurers, etc. - be better at what they do. We see our sweet spot at seeding founders who are marrying in-depth understanding of the complex network of healthcare system participants with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and invest in founders determined to effectively and efficiently serve these participants on the european continent, where we are based, and internationally.​ In our investment criteria and process, we are informed by a Stanford-born methodology of health technology innovation known as Biodesign. Since 2001, Biodesign has proven to de-risk the process of new venture creation by applying a need-driven and value-based approach to reinventing healthcare with the help of technology. To learn more about the methodology, head to The Student Guide to Biodesign, developed by a team of Stanford instructors and students who are passionate about education and making high-quality learning materials available and accessible to all.​ We invest in european companies as well as in selected non-european companies with ties to europe. Wherever they are, our goal is to help founders ready their companies to raise series A capital, and to access international markets. To learn more about our process, click here.

Based on our thesis the convergence of healthcare and technology builds the basis for the next wave of market leaders across the full patient journey. We offer not only financial support, but also immediate access to the German healthcare ecosystem. Heal Capital is backed by leading private health insurances and deeply rooted across the German healthcare ecosystem.

We partner with companies that create entirely new markets. For more than 25 years, and longer than almost any other investor in the country, our Principals have financed and helped build more successful healthcare industry "firsts" and companies that became market leaders. We invest on behalf of many of the largest healthcare organizations in the country, many of healthcare's most accomplished senior executives, and an outstanding group of global institutional investors. Our Principals have worked with strategic investors for longer than almost anyone in the industry. Collectively, Health Velocity Capital’s investors represent organizations that. INSURE MORE THAN 175M AMERICANS OPERATE >700 HOSPITALS PROVIDE PHARMACY & PBM SERVICES TO 75% OF THE NATION EMPLOY 5.0M AMERICANS GENERATE $2.1T IN REVENUE We leverage these relationships to help drive revenue and build teams In a highly process-driven and symbiotic manner, our Principals have used their networks to tangibly create equity value at more than 95% of the companies with which they have partnered. 10,000+ CONVERSATIONS WITH STRATEGIC INVESTORS 1000+ COMPANIES DISCUSSED $40B+ EQUITY VALUE CREATION 100+ EXECUTIVES PLACED 200+ COMMERCIAL RELATIONSHIPS FACILITATED We’re an investment firm that is driven by purpose, a clear mission, and an important set of core values Our mission is to generate outstanding financial returns while being the preferred innovation partner of entrepreneurs and investors working toward a more affordable, sustainable, consumer-friendly healthcare system.

We believe that these solutions cover a wide spectrum that includes the optimization of physical, mental, social and financial wellness, serving as the core components that will undergird the conscious, communal shift toward a healthier future. Our primary goal is to empower passionate founders who develop innovative ideas that impact all bodies. We're investing in more than just potential, we’re doubling down on the endless realm of human potential. With efficiency in mind, we like to spend our first meeting getting to understand the founder(s) first. Your first conversation may be with one of our Partners or investors. Each member of our team has a voice and it's respected at the table. After that conversation, we huddle to connect the dots, reflect on your story and think. From there we spend time with information shared and will come back with deeper questions that move the relationship forward. These are not questions to occupy your inbox, but questions formulated on our path to deep conviction. HEALTH Healthcare has reached an inflection point. The landscape is rapidly shifting towards value based care, deep personalization, and an endless appetite for connected data that will forever change the way we communicate with health providers, our families and ourselves. WELLNESS The wellness industry is a $4.5T opportunity, as more consumers seek to reduce their healthcare costs while exploring ways to be healthier and happier across physical, mental, social and spiritual dimensions of their lives. We seek innovative companies using technology to deliver benefits that are meaningful, measurable and scalable. TECHNOLOGY Software will continue to impact the world in ways never imagined. We're firm in our belief of embracing technology as the conduit for optimization. Innovative applications and connected hardware will continue to change behaviors, augment processes and provide stable infrastructure to advance the world's capabilities. STAGE & CHECK SIZE Our funding decisions are made by consensus. There will always be an internal deal champion that will serve as your lead investor. We practice a rigorous diligence process that can sometimes be complex or very swift - but we typically are able to gather the information we need in 2 weeks or less, once we've aligned on our potential partnership. It's our obligation to earn your trust and build on our relationship. To that end we run a transparent process, with no "GOTCHA" moments. We will work closely with the founder(s) to determine our entry point that makes sense. We are hands-on investors, we set out with a 90 day action plan to be additive at the outset. Stage: Seed-Series A Size: $500K-$3MM Fund Size: $50M As the capital landscape continues to evolve, we remain flexible to understand the specific needs of the entrepreneur. We have a framework that directs our investing. In order for us to spend dedicated time with our founders, we target 6-8 investments per year. These companies typically have a working prototype product getting user feedback or generating revenue, approaching product market fit. On occasion, we invest in exceptional teams at the concept level.

No single company can advance healthcare alone. We accelerate access & quality across healthcare in the Philippines & beyond. Philippines-focused healthcare ventures.Build: We choose high-impact ideas, validate & build them alongside our Entrepreneurs in Residence. With our in-house expertise in launching & scaling, we provide foundational support in the early stages to set our Entrepreneurs up for success & to enable them to focus on the work that truly matters. Partner: We cooperate with companies from outside of the Philippines & within to transform healthcare, through partnerships & joint ventures. We are constantly growing our synergetic ecosystem, building on an already expansive network of health stakeholders, advisors & investors. Invest: We invest up to $250k in promising health-focused companies across stages. Our portfolio spans the entire healthcare landscape, with a special focus on consumer-centric, provider-centric& pharma-centric digital solutions.

By bringing these companies together to share resources, industry specific knowledge, and relationships, Nimbus is accelerating their growth and increasing their likelihood of success. Nimbus is significantly impacting the burgeoning yet underserved digital health and health technology sectors through its leadership as investor, partner, and mentor. WhatSector: Health Technology Restrictions: No Drugs or Class III Devices Geography: Primarily Canada Stage: Seed through Series B Competitive Advantage: Sustainable Lead: We lead most of our investments Cheque Size: $250K - $5M Board Seat: Required Pre-Money:Target: $10M-$20M Synergy: Builds relationships with peers Strong Value Proposition: In-revenue: $75k - $150k MRR Team: Knowledgable, passionate, committed, humble When We believe that engaging early before you are seeking funding is a valuable part of the relationship-building process. It minimizes pressure on both sides and enables a more fluid interaction focusing on what’s most important - you and your venture. And since our investment focus is so well-defined, we hope it is easy for you to determine whether meeting with us will be valuable. We are always happy to have coffee with founders at any stage and learn about their journeys while sharing our experiences, insights, and knowledge in the process. How Our team provides leadership, operational, and financial experience to founders, contributing a mindful view on growth to help teams execute to their fullest potential. We help with many aspects of a company’s growth including: Financings Financial management Board development Strategic relationships Mergers and acquisitions Planning and preparation for public offerings Network of industry and financial contacts We have also designed and implemented value-building initiatives for founders and teams including: CEO Mentorship Experienced Entrepreneurial Advice Facilitated CEO Roundtable Annual CEOs Event Portfolio Social Events Portfolio-wide Communications Platform AWS Activate Provider Discounted/Free Workshops and Seminars Resource Database Why We aspire to improve health through Canadian-led innovation. Innovation is built upon a founder’s vision of how to make the world a better place by solving a really big problem. Building alignment around that vision is critical to a new venture’s success. Identifying a funding partner who believes in your vision as strongly as you do and can help you achieve it is one of the most impactful decisions in your entrepreneurial journey. Raising dilutive capital from external investors will mark the beginning of a long-term relationship that can last more than a decade. In our experiences, company building is not all sunshine, lollipops, and rainbows. Startup journeys are filled with challenges, setbacks, and struggles. Finding the right investor who is going to support you through good times and bad is crucial.